About the journal
Acta Haematologica Polonica is an open-access journal published by Via Medica in Poland, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Via Medica
- ISSN
- 0001-5814 · 2300-7117
- Country
- Poland
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 8
- Declared review time
- 14 weeks
- Declared peer-review model
- double_blind
- Official website
- https://journals.viamedica.pl/acta_haematologica_polonica/index
Index listings
- DOAJ · 2024-06-04
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 14 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
8
Most recent article
14 months ago
Average review time (journal-declared via DOAJ)
14weeks
Works in OpenAlex
1377
Last recorded publication year
2025
h-index
14
i10-index
26
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2025-04-24
- Added to DOAJ
- 2024-06-04
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
Show all subjects (50)
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Platelet Disorders and Treatments
- Platelet Disorders and Treatments
- CAR-T cell therapy research
- Hemophilia Treatment and Research
- Blood groups and transfusion
- Hemophilia Treatment and Research
- Blood groups and transfusion
- CAR-T cell therapy research
- Nutrition and Health Studies
- Nutrition and Health Studies
- Agriculture, Plant Science, Crop Management
- Agriculture, Plant Science, Crop Management
- Neutropenia and Cancer Infections
- Childhood Cancer Survivors' Quality of Life
- Childhood Cancer Survivors' Quality of Life
- Neutropenia and Cancer Infections
- Eosinophilic Disorders and Syndromes
- Eosinophilic Disorders and Syndromes
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- CNS Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Viral-associated cancers and disorders
- Cytomegalovirus and herpesvirus research
- Viral-associated cancers and disorders
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Cytomegalovirus and herpesvirus research
Keywords (DOAJ)
- transfusion medicine
- blood disorders
- hematology
- haematology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ